Activity value 80japan Buyer&Supplier,Last transaction date:
2026-02-27
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for summit pharmaceuticals international from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 12 transactions, with a transaction quantity of 77256 and a transaction weight of 0.
YearTransactionsQuantityWeight
202571337581.861093
202612772560
Bill of lading data
<
1/15
>
Trade date
2026/02/27
B/L No.
5765347
Suppliers
summit pharmaceuticals international
Buyers
jubilant generics ltd.
Product description
HYDROXYPROPYLCELLULOSE L EXCIPIENTS FOR MANUFACTURING OFATORVASTATIN HYDROXYPROPYLCELLULOSE L EXCIPIENTS FOR MANUFACTURING OFA
Expand
Trade date
2026/02/27
B/L No.
6333478
Suppliers
summit pharmaceuticals international
Buyers
jubilant generics ltd.
Suppliers
summit pharmaceuticals international
Buyers
jubilant generics ltd.
POLs
——
PODs
delhi
Supply area
Japan
Purchas area
India
Weight
——
Amount
255.55
Hs code
15211090
Product tags
excipients,teneligliptin,turing,t n c,carnauba wax,table
Product description
CARNAUBA WAX EXCIPIENTS FOR MANUFACTURING OF TENELIGLIPTINTABLET N C V CARNAUBA WAX EXCIPIENTS FOR MANUFACTURING OF TENELIGLIPTINT
Expand
Trade date
2025/12/09
B/L No.
1761870
Suppliers
summit pharmaceuticals international
Buyers
jubilant generics ltd.
POLs
——
PODs
delhi
Supply area
Japan
Purchas area
India
Weight
——
Amount
1187.2
Hs code
29181990
Product tags
excipients,teneligliptin,l lactate,turing,t n c,table
Product description
L LACTATE EXCIPIENTS FOR MANUFACTURING OF TENELIGLIPTIN TABLET N C V L LACTATE EXCIPIENTS FOR MANUFACTURING OF TENELIGLIPTIN TAB
Expand
Trade date
2025/12/09
B/L No.
2337378
Suppliers
summit pharmaceuticals international
Buyers
jubilant generics ltd.
POLs
——
PODs
delhi
Supply area
Japan
Purchas area
India
Weight
——
Amount
817.6
Hs code
29319019
Product tags
excipients,teneligliptin,turing,t n c,magnesium stearate,table
Product description
MAGNESIUM STEARATE EXCIPIENTS FOR MANUFACTURING OF TENELIGLIPTIN TABLET N C V MAGNESIUM STEARATE EXCIPIENTS FOR MANUFACTURING OF TENELIGL
Expand
5presperse corp
otherbuyer,they trade on 2019-07-03
195.29%
>
+View All
Products
Total 56
ProductsTransactionsPerDetail
cyano pyrazine 3743.53%>
atorvastatin 3440%>
turing 3440%>
excipients 3440%>
torva 78.24%>
+View All
Hscode rank
Total 58
HSCode NameTransactionsPerDetail
HS 293399904047.06%>
HS 391239191112.94%>
HS 2931901944.71%>
HS 2934999044.71%>
HS 2933310033.53%>
+View All
Trading Area
Total 6
AreaTransactionsPerDetail
india31387.19%>
united states328.91%>
brazil71.95%>
pakistan51.39%>
indonesia10.28%>
+View All
Port statistics
Total 7
Port NameTransactionsPerDetail
tokyo133.62%>
busan51.39%>
kobe30.84%>
yokohama30.84%>
58886, tokyo10.28%>
+View All
summit pharmaceuticals international is japan Buyer&Supplier,
and primarily engages in the import and export business of products such as cyano pyrazine,atorvastatin,turing.
According to the 52wmb.com global trade database, as of 2026-02-27, the company has completed 1591 international trades,
with its main trading regions covering india,united states,brazil etc.
The core products include HS29339990,HS39123919,HS29319019 etc,
often transported via tokyo,port busan, port kobe etc,
and its main trading partners are jubilant generics ltd.,lupin ltd.,lupin manufacturing solutions limited.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on summit pharmaceuticals international is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.